Jump Financial »

Summit Therapeutics shares owned by Jump Financial

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Jump Financial from 13F filings

Historical chart of Jump Financial investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Jump Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Jump Financial

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.2M 116k 18.96
2025-06-30 $244k 12k 21.28
2024-03-31 $93k 23k 4.14
2023-03-31 $21k 12k 1.75

More positions owned by Jump Financial

iShares Russell 2000 ETF Etf (IWM)
Invesco QQQ Trust Series 1 Etf Call Option (QQQ)
State Street SPDR S&P 500 ETF Trust Etf Call Option (SPY)
iShares iBoxx USD High Yield Corporate Bond ETF Etf Call Option (HYG)
State Street Energy Select Sector SPDR ETF Etf (XLE)
Super Micro Computer Convertible bond (Principal)
iShares Core S&P 500 ETF Etf (IVV)
iShares 20 Year Treasury Bond ETF Etf Call Option (TLT)
State Street Consumer Discretionary Select Sector SPDR ETF Etf (XLY)
iShares Silver Trust Etf (SLV)
Direxion Daily Semiconductor Bull 3X ETF Etf (SOXL)
CME Group Common Stock (CME)
Sandisk Corp Common Stock (SNDK)
Microsoft Corp Common Stock (MSFT)
Alibaba Group Holding Convertible bond (Principal)

View all positions for Jump Financial

Top funds holding Summit Therapeutics

Baker Bros. Advisors
FMR
BlackRock
State Street Corporation
Vanguard Capital Management
Vanguard Portfolio Management
UBS Group
Geode Capital Management
Susquehanna International
D. E. Shaw & Co
Morgan Stanley
Pictet Asset Management Holding SA
Apeiron Capital
Citadel Advisors
Two Sigma Investments

View all funds holding Summit Therapeutics